4
Changes in Ownership
RxSight, Inc. Filed Acc 0001209191-23-059039
President & CEO sold 40,000 shares at an average $39.70 ($1,588,186)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kurtz Ronald M MD President & CEO | 2023-12-14 | Sale 10b5-1 | −20,000 | $40.01 | $800,164 | 909,610 | I |
| Kurtz Ronald M MD President & CEO | 2023-12-14 | Sale 10b5-1 | −20,000 | $39.40 | $788,022 | 889,610 | I |
| Open-market sales · 40,000 sh · avg $39.70 · $1,588,186 | |||||||
Loading xslF345X05/doc4.xml…